Malhotra Uma, Huntsberry Claire, Holte Sarah, Lee Jean, Corey Lawrence, McElrath M Juliana
Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Clin Immunol. 2006 Apr;119(1):95-102. doi: 10.1016/j.clim.2005.11.010. Epub 2006 Jan 5.
CD4+ T cell depletion and dysfunction are the hallmark of HIV-1 disease. Our primary objectives were to define the diversity of the CD4+ T cell receptor Vbeta (TCRBV) repertoire in subjects with HIV-1 infection by CDR3 (complementarity-determining region) length spectratyping and to determine the correlates of CD4+ repertoire perturbation and its restoration with virus suppression. During primary HIV-1 infection, the proportion of perturbed CD4+ TCRBV subfamilies was significantly greater compared to HIV-1 seronegative subjects (median 48% vs. 10%, P = 0.0159). During chronic infection, the extent of repertoire perturbation was significantly associated with higher levels of plasma viremia (Spearman Correlation coefficient, R = 0.65, P = 0.049) and disease progression. Restoration of the repertoire with antiretroviral therapy was variable despite adequate virologic suppression. We speculate that the use of immunomodulators as an adjunct to antiretroviral drugs may enhance immune reconstitution in persons with suboptimal increases in CD4+ T cell counts despite adequate virus suppression.
CD4+ T细胞耗竭和功能障碍是HIV-1疾病的标志。我们的主要目标是通过互补决定区(CDR3)长度频谱分型来确定HIV-1感染受试者中CD4+ T细胞受体Vβ(TCRBV)谱系的多样性,并确定CD4+谱系扰动及其随病毒抑制恢复的相关因素。在原发性HIV-1感染期间,与HIV-1血清阴性受试者相比,受扰动的CD4+ TCRBV亚家族比例显著更高(中位数分别为48%和10%,P = 0.0159)。在慢性感染期间,谱系扰动程度与更高的血浆病毒血症水平(Spearman相关系数,R = 0.65,P = 0.049)和疾病进展显著相关。尽管病毒学抑制充分,但抗逆转录病毒治疗后谱系的恢复情况各不相同。我们推测,尽管病毒抑制充分,但对于CD4+ T细胞计数增加不理想的患者,使用免疫调节剂作为抗逆转录病毒药物的辅助治疗可能会增强免疫重建。